Directs the State Board of Pharmacy to issue a license to operate a mobile pharmacy to a qualified applicant.
Summary
HB 4131 directs the Oregon State Board of Pharmacy to create a licensing framework for mobile pharmacies. The bill requires the board to issue a mobile pharmacy license to eligible applicants that are already registered retail drug outlets with a permanent physical location and that are critical access pharmacies, hospitals, federally qualified health centers, or county governing bodies. It also authorizes the board to set fees and adopt additional rules to administer the program.
The bill sets operating and recordkeeping requirements for mobile pharmacies. A licensed mobile pharmacy must have a pharmacist physically present during operating hours, maintain transfer and dispensing records, record dispensed drugs in the parent outlet’s records within 24 hours, and store drugs and controlled substances securely and in compliance with board and federal requirements. It also requires patient access planning for refills if the mobile unit is unavailable and coordination with local public health authorities on communicable disease reporting. Mobile pharmacies are limited in how long they may remain in one location or within a five-mile radius, though the board must create exceptions for declared public health emergencies and natural disasters and may allow co-location with mobile dental services.
Impact
HB 4131 adds a new section to ORS chapter 689 governing mobile pharmacies and gives the State Board of Pharmacy authority to license, regulate, and collect fees for these operations. It affects retail drug outlets, hospitals, federally qualified health centers, county governments, pharmacists, and patients by creating a legal pathway for pharmacy services to be delivered through mobile units, especially in underserved or emergency-affected areas. The bill also requires rulemaking by the board and deposits fee revenue into the State Board of Pharmacy Account.
Sentiment
The bill appears to have been broadly supported and noncontroversial in the legislative process. It advanced through committee and both chambers with unanimous recorded votes, including 8-0 in a House committee, 21-0 on the House floor, and 30-0 in the Senate. The lack of recorded opposition suggests general agreement that mobile pharmacies could improve access to medications and pharmacy services.
Contention
No major opposition is reflected in the available voting record or transcripts. The main policy questions embedded in the bill concern how tightly mobile pharmacies should be regulated, including limits on how long they may operate in one place, how they must secure controlled substances, and how exceptions should work during emergencies. Any potential concern would likely center on balancing expanded access to care with diversion prevention, patient continuity of service, and local public health coordination, but no specific stakeholder objections are documented in the provided materials.